Collaborating on clinical trials and research
At GSK, a key part of our work is to develop new medicines and vaccines, and in doing so we work closely with healthcare professionals. Our collaborations with doctors and other health experts enable us to better understand the needs of patients, and also to assess the benefits and risks of products we create.
Healthcare professionals throughout New Zealand help us in a variety of ways: they identify potential volunteers for clinical trials of medicines, they administer the investigational medicine or vaccine to their patients, and they monitor the results. Their cooperation, medical insight and specialist knowledge is essential to the development of new treatments.
At the heart of our relationships with healthcare professionals is a shared mission to improve the health of New Zealanders, and we base all our dealings on the core GSK values of transparency, respect, integrity and patient focus.
We have contracts with healthcare professionals who work with us on clinical trials, and they are paid for their work on these projects. This payment covers their time, as well as the cost of investigations they may need to carry out to decide the suitability of a patient for the trial, and the effectiveness of the treatment.
We have strict policies governing all our work with healthcare professionals.
These state that:
- all clinical trial investigators are selected solely on their qualifications to conduct good quality clinical research
- their history of using or not using GSK products must not be taken into account when deciding whether to include them as clinical trial investigators
- no payments are offered or made to influence their judgement on whether to enrol or maintain a patient in a clinical study
- gifts are not permissible to healthcare professionals involved in research projects for GSK
- all payments to HCPs must be governed by contracts
- any payment must reflect fair market value for the work performed and the services provided.
We also have a commitment to publicly disclose the research payments that are made to healthcare professionals, and to their institutions, for conducting clinical research.